CMPX
NASDAQ · Biotechnology

Compass Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$2.02
-0.03 (-1.46%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +2,561.9% upside
Low Target $36.32
Average Target $53.77
High Target $66.75
Current Price $2.02
Current
$2.02
Target
$53.77
$36.32 $53.77 avg $66.75
Scenario Analysis
Bear Case
$36.32
1,698.0%
Low target
Base Case
$53.77
+2,561.9%
Avg target
Bull Case
$66.75
+3,204.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.88
-70.6% from high
52-Week Low
$1.61
+25.5% from low
Target vs 52W High
$53.77
+681.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%